Why is it important to recognize the neurological manifestations of FD? What advantages accrue to the patient from early diagnosis? In which target organs affected by FD can we potentially ameliorate disease progression?

Why is it important to recognize the neurological manifestations of FD? What advantages accrue to the patient from early diagnosis? In which target organs affected by FD can we potentially ameliorate disease progression?

CLICK HERE FOR CME CREDIT

Why is it important to recognize the neurological manifestations of FD? What advantages accrue to the patient from early diagnosis? In which target organs affected by FD can we potentially ameliorate disease progression?

Created by

CMEducation Resources IQ&A Fabry Disease Diagnostic Intelligence Zone

Presenter

Heather Lau, MD

Heather Lau, MD

Assistant Professor, Department of Neurology
Associate Director, Division of Neurogenetics
Director, Lysosomal Storage Disease Program
NYU Langone
New York, NY